Add To...

    NATR  Nature's Sunshine Products Inc...

    Exchange

    NASDAQ

    Sector

    Consumer Durables

    Industry

    Major Pharmaceuticals

    Market Cap.

    262.7M

    Poor Cash Return on Invested Capital over the past 5 years

    NATR has been unable to consistently generate sufficient returns from its investments in buildings, projects and equipment. This could be due to poor management, lack of an economic moat or the capital intensive nature of the business.

    NATR has only created $8.20 of cash for every $100 invested.
    Figures in USD. Fiscal year ends in December
    20072008200920102011
    Free Cash Flow 8.38M -6.73M -2.28M 13.56M 1.49M
    divided by
    Invested Capital 38.32M 47.65M 58.28M 40.17M 43.37M
    Cash ROIC 21.86% -14.13% -3.92% 33.74% 3.43%

    Poor Return on Equity over the past 5 years

    NATR has shown an inability to deliver strong results for shareholders. This could be due to poor management, NATR operating in a highly competitive industry, or having a weak business in general.

    NATR has only generated $5.23 of Earnings for every $100 of Shareholders' Equity.
    Figures in USD. Fiscal year ends in December
    20072008200920102011
    Net Income -8.24M -1.84M 6.12M 8.47M 17.60M
    divided by
    Stockholders' Equity 60.39M 53.68M 57.10M 68.38M 87.44M
    Return on Equity -13.64% -3.42% 10.71% 12.38% 20.13%

    Mediocre Business Performance over the past 6 years

    NATR isn't a strong business and might be consistently attempting to fuel growth with debt or has trouble staying profitable. The lack of predictability in free cash flow should be concerning for the reliability of future earnings.

    NATR has been unable to consistently create value for shareholders.
    Figures in USD. Fiscal year ends in December
    200620072008200920102011
    Free Cash Flow 11.53M 8.38M -6.73M -2.28M 13.56M 1.49M